GENESIS participated ASM Microbe 2024 in US

The ASM (American Society for Microbiology) Microbe, held annually, is one of the largest professional life science organizations in the world. ASM is the home for microbial scientists to connect, learn, discover and prepare for the future, connecting more than 36,000 members and millions of experts around the globe. The exhibition was held on June 13-17, in Atlanta at the Georgia World Congress Center this year.

Hangzhou Genesis Biodetection and Biocontrol Co., Ltd. participated in this prestigious microbiology event with the aim of showcasing our latest diagnostic solutions, networking with industry peers, and gaining insights into emerging trends.

As a leading high-tech IVD and microbiology enterprise specializing in the R&D, production, and sales of in vitro diagnostic devices and microbiology products, Genesis has a strong presence in the global market, with products exported to over 30 countries and regions, including the United States, Japan, Europe and Southeast Asia. 

This year’s ASM Microbe 2024 exhibition provided us with a comprehensive platform to engage with the global microbiology community, explore cutting-edge scientific advancements, and establish valuable industry connections. 

The exhibition featured over 200 sessions, workshops and presentations, covering a wide range of topics from pandemic prevention to microbiome research and antimicrobial resistance. Our team attended more than 20 presentations on microbiological innovations, gaining insights into the latest trends in diagnostics, therapeutics, and preventive measures against infectious diseases. We successfully established connections with clients, potential partners and suppliers, laying the groundwork for future collaborations in the IVD market. 

Based on the insights gained, we will expand our product offerings based on technological advancements showcased at the exhibition.

The ASM Microbe 2024 was a resounding success for Hangzhou Genesis IVD Company. It provided us with a wealth of knowledge and connections that will undoubtedly contribute to innovation and health wellbeing in the IVD sector to the world.